Научная литература
booksshare.net -> Добавить материал -> Медицина -> Джордж А.Г. -> "Анестезия и педиатрия" -> 208

Анестезия и педиатрия - Джордж А.Г.

Джордж А.Г. Анестезия и педиатрия — М.: Медицина, 2003. — 1192 c.
ISBN 5-225-03821-2
Скачать (прямая ссылка): anesteziyavpedeatrii2003.djvu
Предыдущая << 1 .. 202 203 204 205 206 207 < 208 > 209 210 211 212 213 214 .. 1012 >> Следующая

283. Pionkowski RS, Thompson BM. Gruchow HW et al: Resuscitation time in ventricular fibrillation — a prognostic indicator. Ann Emeig Med 12:733, 1983
284. Niemann JT, Cairns CB( Sharma J, Lewis RJ: Treatment of prolonged ventricular fibrillation: immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation 85:281, 1992
285. Tacker Jr WA, Babbs CF, Abendschain DR, Geddes LA: Transchest defibrillation under conditions of hypothermia. Crit Care Med 9:390, 1981
286. Gascho JA, Crompton RS, Cherwek ML, et al: Determinants of ventricular defibrillation in adults. Circulation 60:231, 1979
287. Weaver WD, Hill D, Fahrenbroch CE, et al: Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med 319:66|, 1988
288. Cummins RO, Eisenbetg MS, Litwjn PE, et al: Automatic external denbrillators used by emergency medical technicians. A controlled clinical trial. JAMA 257:1605, 1987
289. Niskanen RA: Automated external defibrillators — experiences with their use and options for their further development. New Horiz 5:137, 1997
290. Atkins DL, Hartley LL, York DK: Accurate recognition and effective treatment of ventricular fibrillation by automated external defibrillators in adolescents. Pediatrics 101:393, 1998
291. Collingsworth KA, Kalman SM, Harrison DC: The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation 50:1217, 1974
292. Constantino RT, Crockett SE, Vasko JS: Cardiovascular effects and dose response relationships of lidocaine. Circulation 36:89, 1967
293. Austen WG, Moran JM: Cardiac and peripheral vascular effects of lidocaine and procainalol. Am J Cardiol 16:701,1965
294. Schunacher RR, Liebereon AD. Childress RH, Williams JF: Hemodynamic effects of lidocaine in patients with heart disease. Am J Cardiol 24:191, 1969
295. Jewitt DE, Kishow Y, Thomas M: Lidocaine in the management of arrhythmias after myocardial infarction. Circulation 37:965. 1968
2%. Chow MSS. Ronfeld RA, Hamilton RA et al: Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs. J Pharmacol Exp Ther 224:531,
1983
297. Chow MSS, Ronfeld RA, Ruffett D, Fieldman A: Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. Am Heart J 102:799, 1981
298. Liclistein E, Chadda KD, Gupta PK: Atrioventricular block with lidocaine therapy. Am J Cardiol 31:277, 1973
299. Chow MS: Intravenous amiodarone: pharmacology, phar-
228 Анестезия в педиатрии
macokinelics, and clinical use. Ann Pharmacol her 30:637,
1996
300. Singh BN, Venkatesh N, Nadcmanec K, et al: The historical development, cellular electrophysiology and pharmacology of amiodarone. Prog Cardiovasc Dis 31:249,
1989
301. Bauman JLClass 111 antiarrhythmic agents: the next wave. Pharmacotherapy I7:76S, 1997
302. Nattel S: Comparative mechanisms of action of an-tiarrhythmic drugs. Am J Caidiol 72:I3F, 1993
303. Cote P, Bourassa MG, Delaye J, et al: Effects of amio-darone on caidiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation 59:1165, 1979
304. Harris L, Kimiira Y, Shaikh NA: Phospholipase inhibition and the electrophysiology of acute ischemia: studies with amiodarone. J Mol Cell Cardiol 25:1075, 1993
305. Bauman JL, Berk Si, Hariman RJ, et al: Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome. Am Heart J 114:1436, 1987
306. Helmy I, Berre J M, Gee G, ct al: U se of intravenous ami -odarone for emergency treatment of life-threatening ventricular arrhythmias. Am Coll Cardiol 12:1015, 1988
307. Podrid PJ: Amiodarone: reevaluation of an old drug. Ann Intern Med 122:689, 1995
308. Roberts SA, Viana MA, Nazari J, et a|: invasive and non-invasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using me-ta-analysis. Pacing Clin Electrophysiol |7:|590, 1994
309. Gonzalez ER, Kannewurf BS, Omato JP: Intravenous amiodarone for ventricular arrhythmias: overview and clinical use. Resuscitation 39:33, 1998
310. Perry JC, KnilansTK, Marlow D, etal: Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol 22:95, 1993
311. Figa FH, Gow RM, Bn mi (ton RM, et al: Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol 74:573, 1994
312. Singh BN: Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Am J Cardiol 78:41, 1996
313. Jessurun GA, Boersma WG, Cryns HJ: Amiodarone-in-duced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment. Drug Saf 18:339, 1998
314. Hilleman D, Miller MA, Parker R, et a|: Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 18.138S, 1998
315. Pfammatter JP. Paul T: New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 18.28, 1997
Предыдущая << 1 .. 202 203 204 205 206 207 < 208 > 209 210 211 212 213 214 .. 1012 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed